Sunday, January 15, 2012

Pfizer tests a concept that could modernize drug studies |

The ability for patients to log into a website and report data electronically creates the possibility of reducing expenses and eliminating some of the inconvenience and demanding requirements, according to people familiar with the clinical trial process. Still, some experts think drug studies require patients and the data they generate for researchers to be more closely monitored than the "virtual’’ trials allow.

Posted via email from Jack's posterous

No comments: